Published in Europace on September 18, 2010
Inpatients are sicker than outpatients; finally it's evidence-based. Europace (2010) 0.83
National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator. Circulation (2015) 0.82
Mortality in patients on renal replacement therapy and permanent cardiac pacemakers. Int J Nephrol (2014) 0.75
Inpatient Complexity in Radiology-a Practical Application of the Case Mix Index Metric. J Digit Imaging (2017) 0.75
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2013) 7.35
Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol (2013) 5.67
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med (2013) 3.76
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm (2007) 3.23
Complications of beta-thalassemia major in North America. Blood (2004) 2.97
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol (2007) 2.79
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant (2013) 2.71
Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol (2013) 2.65
Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 2.55
Importance of catheter contact force during irrigated radiofrequency ablation: evaluation in a porcine ex vivo model using a force-sensing catheter. J Cardiovasc Electrophysiol (2010) 2.47
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol (2013) 2.43
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 2.42
Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood (2006) 2.42
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol (2011) 2.31
Percutaneous coronary intervention and 1 year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction. Eur Heart J (2005) 2.08
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood (2002) 2.02
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm (2006) 1.87
Acupuncture for upper-extremity rehabilitation in chronic stroke: a randomized sham-controlled study. Arch Phys Med Rehabil (2005) 1.86
Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol (2008) 1.79
Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol (2005) 1.78
Towards regenerative therapy for cardiac disease. Lancet (2012) 1.75
Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol (2008) 1.75
Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Heart Rhythm (2006) 1.75
Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica (2007) 1.74
An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting. Alcohol Clin Exp Res (2005) 1.68
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm (2010) 1.66
Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace (2012) 1.64
Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome. Am J Cardiol (2008) 1.63
Intracardiac echocardiographic imaging of the left atrial appendage. Heart Rhythm (2005) 1.63
Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO). Heart Rhythm (2007) 1.61
Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res (2009) 1.61
Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol (2014) 1.59
Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization. Am J Cardiol (2009) 1.57
Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it? Catheter Cardiovasc Interv (2010) 1.57
Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med (2004) 1.55
Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol (2009) 1.54
Interaction of the onset of spring and elevated atmospheric CO2 on ragweed (Ambrosia artemisiifolia L.) pollen production. Environ Health Perspect (2006) 1.54
Integration of cardiac CT/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.54
Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol (2004) 1.53
Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature. Heart Rhythm (2008) 1.53
The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm (2009) 1.52
Mechanism of decrease in mitral regurgitation after cardiac resynchronization therapy: optimization of the force-balance relationship. Circ Cardiovasc Imaging (2009) 1.52
Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res (2009) 1.52
Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50
Variability of coronary venous anatomy in patients undergoing cardiac resynchronization therapy: a high-speed rotational venography study. Heart Rhythm (2007) 1.50
Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm (2007) 1.50
Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome. Eur Heart J (2007) 1.48
Use of electrogram characteristics during sinus rhythm to delineate the endocardial scar in a porcine model of healed myocardial infarction. J Cardiovasc Electrophysiol (2003) 1.47
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol (2005) 1.46
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol (2005) 1.45
A novel pacing method to suppress repolarization alternans in vivo: implications for arrhythmia prevention. Heart Rhythm (2012) 1.44
Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol (2003) 1.43
Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode. Eur J Heart Fail (2012) 1.42
Multiple ICD discharges associated with lead fracture without triggering of high impedance alert. Pacing Clin Electrophysiol (2009) 1.42
Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Ann Emerg Med (2005) 1.40
The impact of respiration on left atrial and pulmonary venous anatomy: implications for image-guided intervention. Heart Rhythm (2005) 1.40
Does prior valve surgery change outcome in patients treated with cardiac resynchronization therapy? J Cardiovasc Electrophysiol (2014) 1.39
Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg (2008) 1.39
Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.38
The coronary venous anatomy: a segmental approach to aid cardiac resynchronization therapy. J Am Coll Cardiol (2005) 1.36
Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation (2007) 1.35
Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol (2013) 1.34
Ablation of left ventricular epicardial outflow tract tachycardia from the distal great cardiac vein. J Am Coll Cardiol (2006) 1.31
Catheter ablation of ventricular epicardial tissue: a comparison of standard and cooled-tip radiofrequency energy. Circulation (2004) 1.30
Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2011) 1.27
Fiber architecture in remodeled myocardium revealed with a quantitative diffusion CMR tractography framework and histological validation. J Cardiovasc Magn Reson (2012) 1.26
The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J (2011) 1.25
Balloon catheter ablation to treat paroxysmal atrial fibrillation: what is the level of pulmonary venous isolation? Heart Rhythm (2007) 1.24
Relationship of the esophagus and aorta to the left atrium and pulmonary veins: implications for catheter ablation of atrial fibrillation. Heart Rhythm (2005) 1.23
Assessment of catheter tip contact force resulting in cardiac perforation in swine atria using force sensing technology. Circ Arrhythm Electrophysiol (2011) 1.20
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica (2008) 1.18
Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2007) 1.17
Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol (2009) 1.15
Atrial tachycardia after ablation of persistent atrial fibrillation: identification of the critical isthmus with a combination of multielectrode activation mapping and targeted entrainment mapping. Circ Arrhythm Electrophysiol (2008) 1.14
Intraprocedural volume imaging of the left atrium and pulmonary veins with rotational X-ray angiography: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2007) 1.13
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace (2015) 1.13
Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.12